Lymphatic Preconditioning for Preservation of Lymphatic Function
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27209125 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Shahnur Ahmed und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: Lymphedema, Lymphatic Vessels, Lymphatic System. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, NIAMS NIH HHS.
Abstract (Originalsprache)
Lymphedema is chronic swelling from lymphatic dysfunction. The vascular delay phenomenon is used in flap reconstruction to increase flap viability through staged selective partial disruption of blood supply to enhance flap survival, followed by flap transfer 7–10 days later. A similar corollary for lymphatics remains unknown. The purpose of this study was to evaluate whether lymphatic preconditioning with staged disruption of lymphatics in the murine hindlimb lymphedema model can be protective against lymphedema. C57BL/6 mice underwent 20 Gy hindlimb irradiation. Group 1 (immediate lymphatic disruption) underwent a circumferential skin incision, complete lymphatic disruption, and popliteal lymph node excision in a single-stage operation. Group 2 (delayed lymphatic disruption) underwent a semi-circumferential inguinal skin incision and dominant lymphatic transection and, 7 days later, received a circumferential skin incision, complete lymphatic transection, and popliteal lymphadenectomy. Paw thickness was measured weekly. Near-infrared laser lymphangiography and immunohistochemistry were performed on D35. Group 2 had a lower average paw thickness (p = 0.0008) and greater lymphatic clearance signal intensity at 24 h (p = 0.0035). Immunohistochemistry indicated an abundance of the lymphatic endothelial-specific marker podoplanin in Group 2 compared to Group 1 (p = 0.03). This study demonstrates evidence for a novel concept of a lymphatic delay phenomenon parallel to the well-known vascular delay phenomenon.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Plastic Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Department of Radiation Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
ORCID-Profile: Shahnur Ahmed, Ganesh Mohan, Angad S Sidhu, Daniel J Konig, Christopher A Subi-Kasozi, Kristen N Calabrese, Mithun Sinha, Aladdin H Hassanein
Förderung
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- NIAMS NIH HHS
- Plastic Surgery Foundation
- Indiana Clinical and Translational Sciences Institute
- NIH LRP
- National Institutes of Health
- Plastic Surgeon Foundation and Indiana Clinical and Translational Sciences Institute Indiana University Health Values Fund
Zitieren
APA
Ahmed, S., Mohan, G., Sidhu, A. S., Konig, D. J., Subi-Kasozi, C. A., Sullivan, S., Jorge, M. D., Calabrese, K. N., Sinex, H. C., Garrett, J., Dynlacht, J. R., Sinha, M., & Hassanein, A. H. (2026). Lymphatic Preconditioning for Preservation of Lymphatic Function. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209125
Vancouver
Ahmed S, Mohan G, Sidhu AS, Konig DJ, Subi-Kasozi CA, Sullivan S, et al. Lymphatic Preconditioning for Preservation of Lymphatic Function. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209125
BibTeX
@article{Ahmed2026,
author = {Ahmed, Shahnur and Mohan, Ganesh and Sidhu, Angad S and Konig, Daniel J and Subi-Kasozi, Christopher A and Sullivan, Steven and Jorge, Miguel D and Calabrese, Kristen N and Sinex, Helen C and Garrett, Joy and Dynlacht, Joseph R and Sinha, Mithun and Hassanein, Aladdin H},
title = {Lymphatic Preconditioning for Preservation of Lymphatic Function},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27209125}
}
EUVIMED